Two-drug regimens with dolutegravir plus rilpivirine or lamivudine in HIV-1 treatment-naïve, virologically-suppressed patients: latest evidences from the literature on their efficacy and safety

ConclusionsThe results so far available support dolutegravir-based two-drug regimens as excellent treatment options for adults with HIV-1 infection, either naïve or already virologically-suppressed on their current antiretroviral regimen.
Source: Journal of Global Antimicrobial Resistance - Category: Infectious Diseases Source Type: research